Literature DB >> 9492674

Alzheimer's disease.

C L Masters1, K Beyreuther.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9492674      PMCID： PMC2665603          DOI： 10.1136/bmj.316.7129.446

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Savings from sub-groups?: Policy guidance and Alzheimer's disease treatments.

Authors:  P McNamee; A Vanoli; D Hutchings; I McKeith; J Bond
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

3.  Neuroprotection in Alzheimer's disease - new strategies for treatment.

Authors:  A Nordberg
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 4.  Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

Authors:  A Nordberg; A L Svensson
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

5.  Differences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer's disease.

Authors:  Ibidapo Akinleye; J Scott Roberts; Charmaine D M Royal; Erin Linnenbringer; Thomas O Obisesan; Grace-Ann Fasaye; Robert C Green
Journal:  J Genet Couns       Date:  2011-06-09       Impact factor: 2.537

6.  Elimination of prions by branched polyamines and implications for therapeutics.

Authors:  S Supattapone; H O Nguyen; F E Cohen; S B Prusiner; M R Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

7.  Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion.

Authors:  T Borchardt; J Camakaris; R Cappai; C L Masters; K Beyreuther; G Multhaup
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

Review 8.  Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.

Authors:  C M VanDenBerg; Y Kazmi; M W Jann
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

Review 9.  Children of persons with Alzheimer disease: what does the future hold?

Authors:  Lissy Jarvik; Asenath LaRue; Deborah Blacker; Margaret Gatz; Claudia Kawas; John J McArdle; John C Morris; James A Mortimer; John M Ringman; Linda Ercoli; Nelson Freimer; Izabella Gokhman; Jennifer J Manly; Brenda L Plassman; Natalie Rasgon; Jeffrey Scott Roberts; Trey Sunderland; Gary E Swan; Phillip A Wolf; Alan B Zonderman
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jan-Mar       Impact factor: 2.703

10.  Electromagnetic fields, oxidative stress, and neurodegeneration.

Authors:  Claudia Consales; Caterina Merla; Carmela Marino; Barbara Benassi
Journal:  Int J Cell Biol       Date:  2012-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.